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Earlier studies on public attitude and risk perception have concluded that the public’s attitudes towards 
biotechnology was primarily driven by several factors such as familiarity, perceived benefits, perceived 
risks, risk acceptance, moral concerns and encouragement. Demographic characteristics have been 
known to affect attitudes towards science. The purpose of this paper is to compare the attitude of the 
Malaysian public towards genetically modified (GM) insulin across several background variables such 
as religion, race, education level and age. A survey was carried out on 1017 respondents stratified 
according to various stakeholder groups in the Klang Valley region. Analyses of Variance (ANOVAs) 
showed significant differences in the mean scores for familiarity of GM insulin across religions, races 
and ages but not across education levels and gender. Both perceived benefits and perceived risks were 
found to differ across races, education levels and gender but not across religions and ages. On the 
other hand, moral concern was found to differ in all four background variables except gender while risk 
acceptance differed across races and gender and encouragement only differed across education levels. 
In conclusion, background variables do have a significant effect on some of the dimensions of 
Malaysians’ attitudes towards modern biotechnology. The research findings will be useful for 
understanding the effect of background variables on public attitudes towards the application of gene 
technology in medicine. More in-depth empirical studies should be carried out to understand the 
underlying causes behind the differences. 
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Abbreviations: GM, Genetically modified; GMOs, genetically 
modified organisms. 
technologies that will accelerate Malaysia’s transforma-
tion into a highly industrialised nation by 2020 (Ninth 
Malaysia Plan, 2006). Accordingly, it has received strong 
governmental support and commitment through financial 
support for its research and development (R and D), 
infrastructure and human resource development. 
Although, medical biotechnology products developed by 
Malaysian researchers have not yet been commercialised, 




GM (genetically modified) medicines from other countries 
are slowly coming into the country. At least 26 
biopharmaceutical products of modern biotechnology 
techniques have already been registered with the Ministry 
of Health Malaysia (MOH) for use in this country (Latifah 
et al., 2007). The list ranges from different types of insulin 
for the treatment of diabetes, growth hormones, drugs for 
the treatment of various kinds of cancers, hepatitis, 
infertility, autoimmune disorders, organ transplants and 
infectious diseases. 
Modern biotechnology has been viewed by many as 
the frontier of the 21st century revolution. It is a powerful 
tool that presents a range of potential environmental, 
social and economic benefits that demands rigorous 
oversight (Kamaldeen and Powell, 2000). However, 
because the advancement in biotechnology has been so 
rapid in the past ten years, it has been the object of an 
intense and divisive debate in advanced countries. The 
debate was typically seen as a conflict between 
supporters who envisage the potential benefits and the 
opposition groups who view GM products as tampering 
with nature (Bloomfield, 2011). Costa-Font and Gil (2009) 
claim that public controversy related to GM foods has 
arisen due to uncertainties and perceived risks to health 
and the environment. Sagar et al. (2000) suggested that, 
a major factor in the emergence of controversies 
surrounding biotechnology has been the neglect of the 
needs, interests and concerns of the primary 
stakeholders, the commoners. Public perceptions, 
understanding and acceptance of genetically modified 
organisms (GMOs) can both promote and hamper the 
commercial introduction and adoption of new technolo-
gies (Kamaldeen and Powell, 2000). 
Modern biotechnology has been classified as a com-
plex emerging issue that exhibits high salience combined 
with limited knowledge on the part of the public. Various 
studies have shown that consumer acceptance of 
modern biotechnology tends to be conditional and 
dependent on many factors (Pardo et al., 2002). With 
respect to the public perception of biotechnology, Kelley 
(1995) proposed that attitudes to genetic engineering 
were determined by the worth of potential benefits 
offered, knowledge of genetic engineering and having a 
scientific world-view, minus the perceived risk (rational 
worries) and anxieties or fears (irrational worries) and 
plus/minus various minor factors. 
Other studies also concluded that the public’s main 
concerns about biotechnology were primarily driven by 
ethical, value and safety concerns (Einsiedel, 1997). 
Meanwhile, according to Hoban (1997), the major 
influences on acceptance seemed to be knowledge level, 
awareness of benefits, confidence and trust. Gaskell et 
al. (2000, 2003) used four dimensions of attitude: Per-
ceived use, risks, moral acceptability and encouragement 
to model patterns of European public response to 
biotechnology. 
Demographic characteristics have been known to affect 





According to Kelley (1995), demographic characteristics 
such as age and gender must be included, because 
some researchers have argued that the continuing 
process of scientific discovery leaves older people behind 
(perhaps because, for many people, scientific knowledge 
acquired at school is rarely updated), and because men 
and women are known to differ on a number of science-
related and technology-related topics. Education needs to 
be included because of its strong connections with 
knowledge and learning. With regard to risk perceptions, 
women have been shown to perceive more risk from a 
hazard than men (Grobe et al., 1999; Frewer, 2000; 
Christoph et al., 2007) and perceived risk tends to 
increase with age, up to a point, and then decrease, 
possibly due to health concerns or ageing (Grobe et al., 
1999). Gaskell et al. (2000, 2003) have also found that 
supporters of biotechnology in Europe were more likely to 
be less than 25 years of age, male and better educated 
while the rejecters were more likely to be female and over 
35 years of age. People’s occupation and religious beliefs 
are also enduring characteristics that shape many social 
and political opinions on a wide range of topics (Kelley, 
1995). Consequently, in a multiracial country like 
Malaysia, it is also important to see whether there is any 
effect of race on attitudes towards biotechnology. People 
from different races usually have a different culture that 
may affect their attitudes. 
The objective of this paper is to study the attitudes of 
Klang Valley stakeholders, across several demographic 
variables, towards an example of a medical biotech-
nology product already available in the Malaysian market: 




MATERIALS AND METHODS 
 
Survey data collection 
 
This is one of the first in-depth studies on public attitudes towards 
modern biotechnology in Malaysia. The people in the Klang Valley 
region were chosen as the targeted population as they are in the 
centre of the country’s economic and social development. There 
are numerous existing universities, R and D institutions, and 
biotechnology-related industries located in this region. In addition, 
and most importantly, the respondents in this region meet the 
requirement of the diversity of backgrounds that uniquely represent 
the Malaysian population.   
In this study, the stakeholder-based approach recommended by 
Aerni (1999, 2002) was adopted but a wider range of interest 
groups including producers, biotechnologists, biologists, policy 
makers, non-governmental organizations (NGOs), the media, 
politicians, religious experts, university students and the general 
public were surveyed. The respondents (n = 1017) were adult 
representatives (aged 18 years old and above) from various interest 
or stakeholders’ groups mentioned earlier (Table 1). Since the 
respective populations for the stakeholders involved were unknown, 
the respondents were chosen using a stratified purposive sampling 
technique, as recommended by Monroe and Monroe (1993). The 
ratios for different gender, races and religion of the residents in the 
Klang Valley were also taken into account. ANOVAs were also 
carried out for attitudes across races, religions, ages and  education  




Table 1. Background of respondents surveyed. 
 
Background Frequency Percentage (%) Background Frequency Percentage (%) 
Stakeholders’ group Age 
Producers 36 3.5 18 - 29 years 464 47.6 
Biotechnologists 30 2.9 30 - 39 years 233 23.9 
Biologists 43 4.2 40 - 54 years 231 24.3 
Policy maker 40 3.9 ≥ 55 years 47 4.2 
NGOs 41 4.0  
Media 38 3.7 Gender   
Politician 38 3.7 Male 463 45.9 
Islamic experts 47 4.6 Female 546 54.1 
Buddhist expert 28 2.8  
Christian expert 26 2.6 Race 
Hindu expert 26 2.6 Malay 609 60.5 
Biology students 46 4.5 Chinese 215 21.4 
General public 578 56.8 Indian 167 16.6 
   Others 15 1.5 
    
Education Religion 
Secondary 251 26.0 Islam 616 61.3 
Pre-University/diploma 197 20.4 Buddha 133 13.2 
Tertiary 519 53.7 Hindu 150 14.9 
   Christian 95 9.5 




levels. The attitudes among the three major races in the Klang 
Valley (Malay, Chinese and Indian) and three levels of education 
(secondary, pre-university and tertiary) were compared. In order to 
have a medium effect size (f = 0.25) at P = 0.05, u = 2, a sample of 
52 subjects per group was required to obtain a power of 0.80 
(Cohen, 1969). Each race and category of education was allocated 
at least a minimum sample size of 52. As for religion and age, four 
major religions (Islam, Buddha, Hindu and Christian) and four 
categories of age (18 to 29, 30 to 39, 40 to 54 and ≥ 55 years) were 
compared. In order to have a medium effect size (f = 0.25) at P = 
0.05, u = 3, a sample of 44 subjects per group was required to 
obtain a power of 0.80 (Cohen, 1969). Each religion and category 
of age needed at least a minimum sample size of 44. A t-test was 
carried out on attitudes across gender. Again, in order to have a 
medium effect size (d = 0.50) at P = 0.05, a sample of 64 subjects 
per group was required to obtain a power of 0.80 (Cohen, 1969). 





The multi-dimensional instrument measuring specific attitudes to 
modern biotechnology applications used in this study was con-
structed based on the work of earlier research (Gaskell et al., 2000; 
Macer, 2000; Rohrmann, 1994; Kirk et al., 2002) and validated in 
an earlier study (Latifah et al., 2004). The instrument measuring 
attitudes towards GM insulin incorporated six dimensions or factors: 
familiarity; perceived benefits; perceived risks; encouragement; 
moral concerns; and risk acceptance. Each dimension or factor 
comprised of several items measured on seven point Likert scales. 
The total six factors were able to account for the majority of the 
variances in attitude responses (72.7%), indicating that, it is a good 
instrument that can measure attitudes towards biotechnology. A 
multivariate analysis by Pardo et al. (2002) on the four factors 
included the widely used Eurobarometer instrument (Gaskel et al., 
2000) which only showed a total of about 38.3% variance in attitude 
responses. A closely-related study by Marris et al. (1996) on factors 
predicting risk perception (which include familiarity and other risk 
aspects) found that the combined factors were able to explain 50% 
of the variances among his respondents. Another study by Kirk et 
al. (2002) showed that the two main components of risk perception 
towards food safety (dread and familiarity) accounted for 43% of the 
variation in responses. Table 2 shows the results of principal 
component factor analyses using varimax rotation. This rotation 
yielded meaningful item groupings or dimensions with strong 
unambiguous loadings. The entire factor loading values was either 
equal to or greater than 5.0, which can be considered as more 
significant (Hair et al., 1992). The first factor or dimension clearly 
reflected the beneficial aspects of biotechnology and was named as 
perceived benefits. Five items strongly loaded highly on it. The 
second dimension with five items also strongly loaded on it was 
labelled as perceived risk. Four items were salient to the third factor 
and labelled as encouragement. Another four items loaded heavily 
on the fourth factor and were interpreted as familiarity. The fifth 
factor, which was made up of another three items, appeared to 
relate to moral aspects and was called moral concerns. Another 
three items were strongly loaded on to the sixth factor which 
represented the acceptance of the risks related to biotechnology 
applications. Hence, this dimension was named risk acceptance. 
Cronbach’s coefficient alpha was used to calculate the reliability of 
all six dimensions and attitude items scales. As Table 2 shows, the 
standardised alpha coefficients of all dimensions were above 0.70, 





Initially, reliability tests and confirmatory factor analysis were carried 




Table 2. Factor loadings and Cronbach’s alpha values for measurement scale of attitude 
towards GM Insulin. 
 
Constructs and observed variables Factor loading α 
Perceived benefit  0.91 
Benefit to Malaysian society  0.80  
Enhance product quality. 0.80  
Enhance quality of life. 0.80  
Enhance Malaysian economy 0.77  
Benefits exceed risks  0.67  
 
Perceived risk  0.91 
Feelings of anxiety  0.81  
Harm to health  0.84  
Long term effect 0.85  
Catastrophic potential 0.84  
Overall risk magnitude 0.65  
 
Encouragement  0.92 
More rigorous R&D  0.79  
Should be commercialized 0.79  
Should be given monetary support by govt. 0.83  
Overall encouragement  0.80  
 
Familiarity  0.74 
Easy to know 0.82  
Easy judgement 0.83  
Effect known 0.78  
Controllability 0.50  
 
Moral concern  0.82 
Threaten natural order of things 0.78  
‘Play god’ 0.88  
Commodify life. 0.85  
 
Risk acceptance  0.80 
Accept if it can boost Malaysian economy 0.74  
Societal acceptance  0.84  




out using SPSS version 12.0 to assess the consistency and uni-
dimensionality of the constructs. ANOVAs were also carried out 
using the same statistical package to compare the differences in 
mean for attitude between respondents of different age, education 
level, religion and race, and a T-test was carried out to see the 
differences in the mean value for attitudes between the different 
genders. When ANOVAs showed significant differences, Post Hoc 
tests were then carried out to detect the differences between 
specific groups. Before running Post Hoc tests, tests of homoge-
neity of variances were employed to determine suitable Post Hoc 
tests. For variables with homogenous variances, Scheffe Post Hoc 
tests were chosen. On the other hand, for variables whose 
variances were not homogenous, Games-Howell Post Hoc tests 
were selected. The minimum significant level accepted in all 
ANOVAs and Post Hoc tests was 0.05. 
RESULTS  
 
Comparison of attitudes across religions 
 
The respondents were not very familiar with GM insulin, 
with their familiarity ratings below the mid-point level of 
4.0 (Table 3). Comparing the familiarity of GM insulin 
across religions, the Hindus led the groups on the fami-
liarity aspects of GM insulin (mean score 3.80) (Table 3). 
ANOVA for the familiarity of GM insulin was significant (F 
= 7.78, p < 0.001). The Scheffe Post Hoc test showed 
that the Hindu’s rating was significantly higher than the 













Islam 3.39 ± 1.26 Moderate 
Buddha 3.27 ± 1.20 Moderate 
Hindu 3.80 ± 1.22 Moderate 
Christian 3.08 ± 1.10 Moderate 
 
Perceived benefit 
Islam 4.39 ± 1.42 Moderate 
Buddha 4.66 ± 1.18 Moderate 
Hindu  4.47 ± 1.52 Moderate 
Christian 4.74 ± 1.39 Moderate 
 
Perceived risk 
Islam 4.58 ± 1.36 Moderate 
Buddha 4.27 ± 1.20 Moderate 
Hindu 4.62 ± 1.45 Moderate 
Christian 4.43 ± 1.21  Moderate 
 
Risk acceptance 
Islam 3.99 ± 1.31 Moderate 
Buddha 4.23 ± 1.16 Moderate 
Hindu 3.84 ± 1.56 Moderate 
Christian 4.14 ± 1.34 Moderate 
 
Moral concern 
Islam 3.77 ± 1.56 Moderate 
Buddha 4.40 ± 1.50 Moderate 
Hindu  4.53 ± 1.69 Moderate 
Christian 4.43 ± 1.56  Moderate 
 
Encouragement 
Islam 4.43 ± 1.54 Moderate 
Buddha 4.55 ± 1.26 Moderate 
Hindu 4.45 ± 1.61 Moderate 
Christian 4.45 ±1.42 Moderate 
 
* Mean score: 1 - 2.99 low, 3.0 - 5.0 moderate, 5.1 - 7.0 high; Std 




ing on familiarity was the second highest (mean score 
3.39). Their mean score was significantly lower than the 
Hindus. 
The benefits, risks, risk acceptance and encourage-
ment of GM insulin surveyed were perceived as 
moderate by respondents from all religions (Table 3). 
ANOVAs did not show any significant differences in their 
opinion at p < 0.05. 
ANOVA was significant for moral concerns of GM 
insulin across religions (F = 14.73, p < 0.001). Muslims 
judged the moral aspects of GM insulin as the lowest and 
the Scheffe Post  Hoc  test  confirmed  that  their  ranking  








Comparison of attitudes across races 
 
Respondents from all races were not familiar with GM 
insulin. Their familiarity ratings were lower than the mid-
point value of 4.0 (Table 4). ANOVA was significant for 
the familiarity of GM insulin across races (F = 7.64, p < 
0.001). The Indians were more familiar with GM insulin 
compared to the Chinese and the Malays. The Scheffe 
Post Hoc test confirmed that the perceived familiarity of 
GM insulin was significantly different between the Indians 
and other races. 
All races perceived moderate benefits of GM insulin 
(Table 4). ANOVA was significant for the perceived 
benefits of GM insulin across races. The Games Howell 
Post Hoc test showed that the Chinese were more 
familiar with GM insulin compared to the Malays and 
Indians. 
The respondents perceived moderate risks of GM 
insulin (Table 4). ANOVA was significant for perceived 
risks of GM insulin (F = 6.36, p < 0.01) across races. The 
Games Howell Post Hoc test showed significant diffe-
rences in the risk opinion of GM insulin by the Chinese 
compared to the Malays and Indians (Table 4). 
The risk acceptance levels of GM insulin by respon-
dents from all races were in the moderate range (Table 
4). ANOVA was significant for risk acceptance of GM 
soybean across races (F = 4.54, p < 0.05). The Games 
Howell Post Hoc test showed that the Chinese 
acceptance of the risk associated with GM soybean was 
significantly higher than the Malays’ and the Indians’. 
All races perceived the moral aspects of GM soybean 
as moderate (Table 4). ANOVA was significant for the 
moral concerns of GM soybean across races (F = 18.18, 
p < 0.001). The Games Howell Post Hoc test showed that 
the Malays significantly showed the lowest concerns of 
the moral aspects of GM soybean, followed by the 
Chinese and the Indians. Respondents from the three 
races professed moderate encouragement for GM 
soybean (Table 4). Although the highest mean score for 
encouragement of GM soybean was scored by the 




Comparison of attitudes across ages 
 
The familiarity level of the respondents with GM insulin 
was below the mid-point value of 4.0 (Table 5). ANOVA 
was significant for the familiarity of GM insulin across 
ages (F = 4.82, p < 0.01). The Scheffe Post Hoc tests 
showed that the youngest age group surveyed (18 to 29 
years) had a significantly higher familiarity with GM 
insulin compared to the oldest group (≥ 55 years). 
Respondents  from   all   age   groups  considered  GM  












Malay 3.38 ± 1.26 Moderate 
Chinese 3.22 ± 1.16 Moderate 
Indian 3.70 ± 1.24 Moderate 
 
Perceived benefit 
Malay 4. 40 ± 1.42 Moderate 
Chinese 4.76 ± 1.16 Moderate 
Indian 4.42 ± 1.57  Moderate 
 
Perceived risk 
Malay 4.57 ± 1.36 Moderate 
Chinese 4.21 ± 1.16 Moderate 
Indian 4.62 ±1.50 Moderate 
 
Risk acceptance 
Malay 3.99 ± 1.31 Moderate 
Chinese 4.25 ± 1.18 Moderate 
Indian 3.85 ± 1.59 Moderate 
 
Moral concern 
Malay 3.79 ± 1.57 Moderate 
Chinese 4.31 ± 1.56 Moderate 
Indian 4.46 ± 1.71 Moderate 
 
Encouragement 
Malay 4.42 ± 1.54 Moderate 
Chinese 4.62 ± 1.28 Moderate 
Indian 4.35 ± 1.63 Moderate 
 





insulin as having moderate moral concerns (Table 5). 
ANOVA showed significant differences in the moral 
aspects of GM insulin across ages (F = 2.74, p < 0.05). 
The Scheffe Post Hoc test confirmed that the youngest 
group of respondents perceived lower moral concerns 
than the oldest group with respect to GM insulin. GM 
insulin was perceived as having moderate benefits, risks, 
risk acceptance and encouragement by the respondents 
from all age groups (Table 5). ANOVAs did not show any 
significant differences across ages for the four 
dimensions of attitude. 
 
 
Comparison of attitudes across education  
 













18 - 29 years 3.50 ± 1.20 Moderate 
30 - 39 years 3.27 ± 1.26 Moderate 
40 - 54 years 3.33 ± 1.29 Moderate 
≥ 55 years 2.86 ± 1.33 Low 
 
Perceived benefit 
18 - 29 years 4.47 ± 1.39 Moderate 
30 - 39 years 4.54 ± 1.33 Moderate 
40 - 54 years 4.48 ±1.42 Moderate 
≥ 55 years 4.21 ± 1.77 Moderate 
 
Perceived risk 
18 - 29 years 4.48 ± 1.28 Moderate 
30 - 39 years 4.43 ± 1.37 Moderate 
40 - 54 years 4.55 ± 1.42 Moderate 
≥ 55 years 4.73 ±1.60 Moderate 
 
Risk acceptance 
18 - 29 years 4.07 ± 1.24 Moderate 
30 - 39 years 4.05 ± 1.29 Moderate 
40 - 54 years 4.00  ± 1.45 Moderate 
≥ 55 years 3.60 ± 1.82 Moderate 
 
Moral concern 
18 - 29 years 3.96 ± 1.49 Moderate 
30 - 39 years 4.00 ± 1.68 Moderate 
40 - 54 years 4.08 ± 1.73 Moderate 
≥ 55 years 4.65 ± 1.64  Moderate 
 
Encouragement 
18 - 29 years 4.51 ± 1.47 Moderate 
30 - 39 years 4.46 ±1.47 Moderate 
40 - 54 years 4.39 ± 1.53 Moderate 
≥ 55 years 4.16 ±1.83 Moderate 
 





pondents from all categories of education were not 
familiar with GM insulin (the mean scores were below the 
mid-point value of 4.0) and ANOVA did not show any 
significant differences in their ratings across education 
levels. 
A moderate level of perceived risks and moral 
concerns were professed by the three groups of 
respondents based on education levels (Table 6). When 
ANOVAs were carried out, the results showed significant 
differences in their concerns towards the risks of GM 
insulin (F = 11.17, p < 0.001) and moral concerns (F = 





Table 6. Attitudes towards GM insulin across education levels. 
 




Secondary 3.46 ± 1.38 Moderate 
Diploma/pre-University 3.33 ± 1.16 Moderate 
Tertiary  3.38 ±1.21 Moderate 
 
Perceived benefit 
Secondary 4.41 ± 1.29 Moderate 
Diploma/pre-University 4.18 ± 1.47 Moderate 
Tertiary 4.65 ± 1.43 Moderate 
 
Perceived risk 
Secondary 4.69 ± 1.30 Moderate 
Diploma/pre-University 4.72 ± 1.27 Moderate 
Tertiary 4.29 ± 1.40 Moderate 
 
Risk acceptance 
Secondary 4.03 ± 1.29 Moderate 
Diploma/pre-University 3.91 ± 1.28 Moderate 
Tertiary 4.09 ± 1.41 Moderate 
 
Moral concern 
Secondary 4.15 ± 1.61 Moderate 
Diploma/pre-University 4.23 ± 1.46 Moderate 
Tertiary 3.90 ± 1.66 Moderate 
 
Encouragement 
Secondary 4.43 ± 1.48 Moderate 
Diploma/pre-University 4.16 ± 1.51 Moderate 
Tertiary 4.60 ± 1.51 Moderate 
 





significant differences in the opinion of the degree 
holders towards the perceived risks of GM insulin 
compared to those with lower levels of education. The 
degree holders seemed to be less concerned with the 
risks of GM insulin. Although the degree holders tended 
to be less concerned with the moral aspects of GM 
insulin (mean score lower, Table 6) compared to those 
with lower levels of education, Post Hoc tests could not 
detect the differences. 
The respondents perceived a moderate level of 
benefits; moderately accepting the risks associated with 
GM insulin and was moderately encouraging of it. 
ANOVAs were significant for perceived benefits and 
encouragement, but not for risk acceptance across edu-
cation levels. The Games Howell Post Hoc test showed 
that the respondents with a degree level of education or 
higher was inclined to see more benefits of GM insulin. 
The Scheffe Post Hoc test confirmed that they were also  




more encouraging of GM insulin compared to those with 
only a diploma/pre-university level of education.  
 
 
Comparison of attitudes across gender 
 
Both the male and female respondents were not familiar 
with GM insulin (mean score below the mid-point level of 
4.0) and rated five attitudinal dimensions (perceived 
benefits, perceived risks, moral concerns, risk accep-
tance and encouragement) as moderate (Table 7). In 
order to compare differences in attitudes across gender, 
T-tests were carried out. The results of the T-tests 
showed that the males perceived less risks (t = −2.27, p < 
0.05) and saw more benefits of GM insulin (t = 2.62, p < 
0.01) compared to the females. However, both genders 
were more in agreement in their opinion on the familiarity, 
moral aspects, risk acceptance and encouragement of 





Ethnicity is referred to as shared origins and culture 
(Loustaunau and Sobo, 1997). Therefore, ethnicity or 
race formulates a cultural/social network. In Malaysia, 
religion is almost synonymous with race, though there are 
exceptions of the same religion but different races. The 
majority of Malays are Muslims, Chinese are Buddhists, 
and Indians are Hindu, so in the following discussion they 
will be treated as such. The Chinese/Buddhists and the 
Malays/Muslims were found to be more positive towards 
modern biotechnology compared to the Indians/Hindus. 
The Chinese/Buddhists rated the risks associated with 
GM insulin as the lowest, the most accepting of its risks 
and the most encouraging of its application. On the other 
hand, the Malays/Muslims rated the moral aspects of GM 
insulin as the lowest. Although the Indians/Hindus 
claimed to be the most familiar with GM insulin compared 
to the other races/religions, their ratings of the other 
attitude variables were lower than the above two 
races/religions but the mean scores were still within the 
moderate levels. Differences in some dimensions of 
attitude towards GM insulin across religions and races 
are supported by earlier theory and studies. According to 
the cultural approach of risk research, the evaluative 
process of risk perception is determined by the norms, 
value systems and cultural idiosyncrasies of societies or 
societal groups (Rohrmann, 1994). Macer et al. (2000) 
also noticed that there was diversity of opinion and 
reasoning across different cultures. Lorence et al. (2006) 
reported an association between race and health 
information-seeking behaviour while Tucker et al. (2006) 
found that white respondents tended to perceive lower 
levels of perceived food risks compared to non-white 
respondents. More in-depth study is needed to under-
stand these differences in attitudes across religions and 
races.  




Table 7. Attitude towards GM insulin across gender. 
 
Attitude dimension Mean score ± Std dev. t-value Significance 
Familiarity  
Male 3.38 ± 1.29 0.42 0.675 
Female  3.41 ± 1.21 - - 
 
Benefit 
Male 4.61 ± 1.39 2.62 0.009** 
Female 4.37 ± 1.41 - - 
 
Risk 
Male 4.40 ± 1.38 - 0.024* 
Female 4.59 ± 1.33 2.27 - 
 
Risk acceptance 
Male 4.12 ± 1.32 2.11 0.036* 
Female 3.94 ± 1.36 - - 
 
Moral concern 
Male 3.99 ± 1.69 - 0.575 
Female 4.05 ± 1.54 0.56 - 
 
Encouragement    
Male 4.54±1.52 1.78 0.076 
Female 4.37±1.50   
 




Younger respondents (18 to 29 years) were found to 
have more familiarity with GM insulin compared to the 
older groups. This could be due to the fact that the 
younger generation were either still studying in univer-
sities or just beginning their career, where they were 
more likely to be involved in information seeking. Lorence 
and Park (2006) reported that younger participants (18 to 
29) exhibited the highest rates in the use of the internet. 
Although, the younger respondents claimed to be more 
familiar with GM insulin, there were no significant 
differences in their attitude towards GM insulin except for 
the dimension and moral concerns. The younger subjects 
seemed to see lower moral aspects of the three modern 
biotechnology applications, compared to older respon-
dents. Lin et al. (2004), Hossain et al. (2002), and Chern 
and Rickertsen (2002) also found that age does not have 
a statistically significant effect on the acceptance of 
selected biotech foods. 
Education has a significant impact on attitudes towards 
GM insulin. ANOVA showed some indications that 
respondents with higher education tended to be more 
positive about GM insulin. The subjects with a tertiary 
level of education seemed to perceive lower risks and 
moral concerns associated with GM insulin and were 
more encouraging of its applications compared to those 
with a lower level of education. Although ANOVAs were 
not significant, the mean scores for perceived benefits 
and risk acceptance of GM insulin were also higher for 
the respondents with a tertiary education compared to 
those with lower education levels. The Eurobarometer 
52.1 survey (INRA (Europe) – ECOSA, 2000) also 
reported an increase in the mean score for the item 
beneficial aspect and risk acceptance of GM food with an 
increase in the level of education. On the other hand, 
there was a decrease in the mean score for the items 
related to risk (GM food causes great alarm and GM food 
is simply not necessary) and items related to moral 
concerns (GM food threatens the natural order of things 
and even if GM food has an advantage, it is basically 
against nature). In a more recent study, Tucker et al. 
(2006) found that respondents with higher levels of 
education tended to perceive lower levels of perceived 
risk. The positive effect of a higher education level could 
be due to more exposure to the culture and power of 
science, as suggested by Priest (2000).  
Although there was no significant difference in the 
familiarity towards GM insulin across gender, males were 
found to be less critical with a significantly lower risk 
rating, higher benefits and higher risk acceptance of GM 
insulin compared to females. Gender has been strongly 
associated with risk judgement and attitude (Slovic, 





risks as smaller as and less problematic than women 
(Brody, 1984; De Joy, 1992; Sjoberg and Drotz-Sjoberg, 
1994). Women were found to be more concerned about 
human health and safety because they are socialised to 
nurture and maintain life (Sterger and Witte, 1989). On 
the other hand, Slovic (2004) proposed that, the reason 
why women see the world as more dangerous is 
because, in many ways, they are more vulnerable and 
they have less power and control over what happens in 
their communities and their lives. However, both genders 
were more in agreement in their opinion of the moral 
aspects and encouragement of GM insulin. Hossain et al. 
(2002) and Chern and Rikertsen (2002) found no effect of 
gender on the acceptance of biotech food while Lin et al. 
(2004) found a low impact of gender on only one biotech 
product (livestock products fed with biotech corn) but no 
effect of gender on the other three biotech products 
surveyed (biotech soybean oil, input-trait biotech rice and 





The empirical results of this study indicate that back-
ground variables such as religion, race, age, education 
level and gender have significant effect on some of the 
dimensions of Malaysians’ attitudes towards modern 
biotechnology. These differences should be taken into 
consideration constructively rather than negatively by the 
government policy makers and regulators to understand 
the social construct of public attitudes towards the 
application of gene technology in medicine. More in-
depth empirical studies should be carried out to 
understand the underlying causes behind the differences 
so that appropriate measures can be confidently intro-
duced to address the issues on what is lacking and what 
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